IDH1 and central nervous system cancer: The most common mutations affect the genes coding isocitrate dehydrogenases: IDH1 (cytosolic) and IDH2 (mitochondrial) and are detected in about 70–80% of grade II/III gliomas (and secondary glioblastomas, grade IV) [6].